Lin Hai-Zha
Analyst
China Biotech
Equibles does not estimate personal net worth.
About Lin Hai-Zha
Lin Hai-Zha is recorded as Analyst at China Biotech. Lin Hai-Zha has spoken on 1 investor event across 1 company, most recently for BeOne Medicines Ltd. on June 8, 2026. The companies whose calls Lin Hai-Zha spoke on are classified in the Healthcare sector.
Lin Hai-Zha on recent calls
“Today, with great privilege, we have the opportunity to host the management from B1 Medicines. On the further right of the stage, we have Aaron Rosenberg, the CFO, and Mark Lanasa, the CMO, joining this file side chat.”
Affiliation history
-
China Biotech
Analyst
Transcript header (unverified)
Current